MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31.

Income Overview

Net Income
-$11,912K
EPS
$8.96
Unit: Thousand (K) dollars

Income Statement
2025-12-31
Research And Development
7,140
General And Administrative
4,492
Total operating expenses
11,632
Operating loss
-11,632
Financial expenses
277
Loss before income taxes
-11,909
Income tax
3
Net loss for the year
-11,912
Basic EPS
8.96
Diluted EPS
8.96
Basic Average Shares
1,329,515
Diluted Average Shares
1,329,515
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss for the year-$11,912K Loss before incometaxes-$11,909K Income tax$3K Operating loss-$11,632K Financial expenses$277K Total operatingexpenses$11,632K Research And Development$7,140K General AndAdministrative$4,492K

Silexion Therapeutics Corp (SLXN)

Silexion Therapeutics Corp (SLXN)